Financials
- Market Capitalization 49.45 M
- Employee 21
- Founded 2015
- CEO N/A
- Website www.inmunebio.com
- Headquarter Nevada, United States
- FIGI BBG00LW94L98
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.84
ratio cours/chiffre d'affaires
772.44
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4290 | TCRT Alaunos Therapeutics, Inc. - Common Stock | 2.06 USD | -0.96% | +0.98% | -13.08% | -22.82% | 50.31 M USD | ||
| 4303 | MGX Metagenomi Therapeutics, Inc. - Common Stock | 1.33 USD | +0.76% | +8.13% | +9.02% | -7.64% | 50.07 M USD | ||
| 4309 | ATYR aTyr Pharma, Inc. - Common Stock | 0.51 USD | +2.00% | -26.09% | +8.51% | -47.42% | 50.01 M USD | ||
| 4349 | HYPD Hyperion DeFi, Inc. - Common Stock | 2.97 USD | 0.00% | -7.48% | +3.12% | -75.25% | 45.02 M USD |